Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection (Q37739949)

22 August 2017

1 reference

title

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection (English)

1 reference

22 August 2017

0 references

hepatocellular carcinoma

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Brad Q Starley

1

1 reference

22 August 2017

Christopher J Calcagno

series ordinal

2

1 reference

22 August 2017

Stephen A Harrison

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

51

1 reference

22 August 2017

1820-1832

1 reference

22 August 2017

5

1 reference

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

22 August 2017

1 reference

7 January 2021

Global cancer statistics in the year 2000.

1 reference

7 January 2021

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

7 January 2021

Primary liver cancer: worldwide incidence and trends

1 reference

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

7 January 2021

Non-alcoholic steatohepatitis and cancer

1 reference

7 January 2021

Epidemiology and natural history of NAFLD and NASH.

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a clinical review

1 reference

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

7 January 2021

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

7 January 2021

Chronological development of elevated aminotransferases in a nonalcoholic population

1 reference

7 January 2021

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

1 reference

7 January 2021

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

1 reference

7 January 2021

Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis

1 reference

7 January 2021

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

7 January 2021

Diagnosis and therapy of nonalcoholic steatohepatitis

1 reference

7 January 2021

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

1 reference

7 January 2021

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

1 reference

7 January 2021

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

1 reference

7 January 2021

Is NASH underdiagnosed among African Americans?

1 reference

7 January 2021

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

7 January 2021

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

7 January 2021

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

7 January 2021

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

7 January 2021

Nonalcoholic fatty liver disease (NAFLD) two decades later: are we smarter about its natural history?

1 reference

7 January 2021

Epidemiology and natural history of non-alcoholic steatohepatitis

1 reference

7 January 2021

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

7 January 2021

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

1 reference

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

7 January 2021

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

1 reference

7 January 2021

Long-term follow-up of patients with nonalcoholic fatty liver

1 reference

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

7 January 2021

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

1 reference

7 January 2021

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

7 January 2021

Two cases from the spectrum of nonalcoholic steatohepatitis

1 reference

7 January 2021

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

1 reference

7 January 2021

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

1 reference

7 January 2021

Obesity and diabetes as a risk factor for hepatocellular carcinoma

1 reference

7 January 2021

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Obesity and hepatocellular carcinoma

1 reference

7 January 2021

Variations in mortality by weight among 750,000 men and women

1 reference

7 January 2021

A prospective study of obesity and cancer risk (Sweden).

1 reference

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

7 January 2021

Obesity and cancer risk: a Danish record-linkage study.

1 reference

7 January 2021

Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study.

1 reference

7 January 2021

Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea

1 reference

7 January 2021

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

1 reference

7 January 2021

Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.

1 reference

7 January 2021

Excess risk of primary liver cancer in patients with diabetes mellitus

1 reference

7 January 2021

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

1 reference

7 January 2021

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

1 reference

7 January 2021

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

1 reference

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

7 January 2021

EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer

1 reference

7 January 2021

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

7 January 2021

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

1 reference

7 January 2021

Iron in NASH, chronic liver diseases and HCC: how much iron is too much?

1 reference

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

7 January 2021

Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis

1 reference

7 January 2021

Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

1 reference

7 January 2021

Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis

1 reference

7 January 2021

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver

1 reference

7 January 2021

Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis

1 reference

7 January 2021

The pathology of hepatitis C

1 reference

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Histopathology of chronic hepatitis C in relation to epidemiological factors

1 reference

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

7 January 2021

Histopathology of hepatitis C virus infection

1 reference

7 January 2021

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.

1 reference

7 January 2021

Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus

1 reference

7 January 2021

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

1 reference

7 January 2021

1 reference

7 January 2021

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?

1 reference

7 January 2021

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis

1 reference

7 January 2021

Hepatocellular carcinoma with nonalcoholic steatohepatitis

1 reference

7 January 2021

Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.

1 reference

7 January 2021

[Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]

1 reference

7 January 2021

Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma

1 reference

7 January 2021

Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid

1 reference

7 January 2021

Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.

1 reference

7 January 2021

Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.

1 reference

7 January 2021

Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases

1 reference

7 January 2021

Primary liver cancers with nonalcoholic steatohepatitis

1 reference

7 January 2021

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?

1 reference

7 January 2021

Liver disease in patients with diabetes mellitus

1 reference

7 January 2021

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

1 reference

7 January 2021

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

1 reference

7 January 2021

Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

1 reference

7 January 2021

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

1 reference

7 January 2021

Adiponectin: a link between excess adiposity and associated comorbidities?

1 reference

7 January 2021

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

1 reference

7 January 2021

Mitochondrial adaptations to obesity-related oxidant stress

1 reference

7 January 2021

The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma

1 reference

7 January 2021

Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia

1 reference

7 January 2021

Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

1 reference

7 January 2021

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

1 reference

7 January 2021

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

1 reference

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

7 January 2021

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease

1 reference

7 January 2021

JNK1 but not JNK2 promotes the development of steatohepatitis in mice.

1 reference

7 January 2021

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

1 reference

7 January 2021

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

1 reference

7 January 2021

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation

1 reference

7 January 2021

Beyond apoptosis of JNK1 in liver cancer

1 reference

7 January 2021

Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation

1 reference

7 January 2021

Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23594

1 reference

release_63dif7uehzbexclqvd2intklv4

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/63dif7uehzbexclqvd2intklv4

24 November 2022

mapped directly with Wikidata item

1 reference